Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

North American Institute for Continuing Medical Education (NAICE)

Status

Completed

Conditions

Injury of Shoulder Region

Treatments

Drug: Exparel block in arthroscopic shoulder surgery

Drug: Bupivacaine block in shoulder surgery

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT02554357

NAICE-002

Details and patient eligibility

About

Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.

Full description

The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm.

Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB.

Enrollment

50 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Dutch or English speaking adults
18 years or older ASA I-III physical class
Scheduled for elective arthroscopic shoulder surgery

Exclusion criteria

History of allergy to a local anesthetic
Baseline neurological deficit
Medical condition that would make it difficult to assess sensory distribution or communicate with the investigators' staff
Recent history (< 3 months) of drug or alcohol abuse
Concomitant opioid therapy
Preexisting coagulation disorder
Infection at the injection site
Pregnancy